Molecules with extended half-lives, compositions and uses thereof

Details for Australian Patent Application No. 2008201419 (hide)

Owner Board of Regents, The University of Texas System MedImmune, LLC

Inventors Johnson, Leslie S.; Ward, Elizabeth Sally; Dall'acqua, William

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008201419

Parent 2002248184

Filing date 27 March 2008

Wipo publication date 24 April 2008

Acceptance publication date 1 September 2011

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 49/00 (2006.01) Preparations for testing

A61P 31/16 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/08 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from viruses

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

G01N 33/534 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with radioactive label

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

17 April 2008 Complete Application Filed

24 April 2008 Application Open to Public Inspection

  Published as AU-B-2008201419

2 October 2008 Alteration of Name

  The name of the applicant has been altered to Board of Regents, The University of Texas System; MedImmune, LLC

1 September 2011 Application Accepted

  Published as AU-B-2008201419

12 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008201420-A Fastener

2008201418-Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment and management of macular degeneration